IRIS
LIAKOULI, Vasiliki
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.049
AS - Asia 2.966
EU - Europa 2.912
SA - Sud America 287
AF - Africa 45
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.277
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.981
SG - Singapore 1.316
IE - Irlanda 693
CN - Cina 659
RU - Federazione Russa 529
SE - Svezia 360
TR - Turchia 321
IT - Italia 303
HK - Hong Kong 279
DE - Germania 270
BR - Brasile 254
VN - Vietnam 235
UA - Ucraina 196
GB - Regno Unito 183
FR - Francia 138
FI - Finlandia 89
NL - Olanda 50
CA - Canada 45
IN - India 44
BE - Belgio 35
JP - Giappone 28
ZA - Sudafrica 21
BD - Bangladesh 16
PL - Polonia 16
MX - Messico 15
ID - Indonesia 11
ES - Italia 10
CZ - Repubblica Ceca 8
AR - Argentina 7
IQ - Iraq 7
SA - Arabia Saudita 7
AU - Australia 6
EC - Ecuador 6
EU - Europa 6
VE - Venezuela 6
CO - Colombia 5
LT - Lituania 5
MA - Marocco 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
UZ - Uzbekistan 5
JO - Giordania 4
LB - Libano 4
PK - Pakistan 4
PT - Portogallo 4
AT - Austria 3
DZ - Algeria 3
EG - Egitto 3
IR - Iran 3
JM - Giamaica 3
KZ - Kazakistan 3
MY - Malesia 3
AL - Albania 2
BO - Bolivia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GR - Grecia 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
LU - Lussemburgo 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
SN - Senegal 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
RO - Romania 1
Totale 11.277
Salva come PNG Salva come JPEG
Città #
Jacksonville 775
Singapore 733
Chandler 723
Dublin 693
San Jose 449
Ashburn 298
Dallas 292
Hong Kong 274
Santa Clara 241
Boardman 230
Izmir 201
The Dalles 150
Ann Arbor 135
New York 133
Nanjing 121
Beijing 109
Moscow 103
Lawrence 101
Princeton 101
Wilmington 100
San Mateo 93
Ho Chi Minh City 78
L'aquila 72
Los Angeles 51
Woodbridge 51
Dearborn 49
Lauterbourg 47
Milan 46
Hanoi 43
Nanchang 43
Brussels 35
Munich 33
Amsterdam 32
Shenyang 30
Seattle 28
Tokyo 28
Mountain View 27
Hefei 26
São Paulo 26
Verona 26
Council Bluffs 25
Helsinki 25
Kunming 25
Shanghai 24
Jiaxing 23
Hebei 22
Dong Ket 20
Des Moines 19
Frankfurt am Main 19
Changsha 18
Rome 18
Columbus 15
Johannesburg 15
Orem 15
Phoenix 15
Tianjin 15
L’Aquila 14
Warsaw 14
Jinan 13
Montreal 12
Chicago 11
Houston 11
Zhengzhou 11
Manchester 10
Chennai 9
Da Nang 9
Haiphong 9
London 9
Ningbo 9
Pune 9
Rio de Janeiro 9
Stockholm 9
Atlanta 8
Denver 8
Grafing 8
Guangzhou 8
San Francisco 8
Toronto 8
Biên Hòa 7
Falkenstein 7
Hangzhou 7
Mumbai 7
Norwalk 7
Nuremberg 7
Pescara 7
Philadelphia 7
Ankara 6
Bremen 6
Brno 6
Jakarta 6
Poplar 6
Salerno 6
Belo Horizonte 5
Lanzhou 5
Tashkent 5
Amman 4
Brooklyn 4
Bắc Ninh 4
Changchun 4
Charlotte 4
Totale 7.482
Salva come PNG Salva come JPEG
Nome #
Studio dell’espressione della chemochina SDF-1 e del suo recettore CXCR4 nella cute e nelle cellule endoteliali microvascolari di pazienti affetti da sclerosi sistemica (SSc). 194
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 158
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 157
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 154
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 153
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 152
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 151
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 149
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 149
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 147
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 145
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 138
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome. 137
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 135
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 135
Cardiovascular disease in primary sjögren’s syndrome 130
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 130
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 129
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 127
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 127
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 126
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease 125
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 125
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 125
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 124
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 121
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 121
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 120
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 120
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 119
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 118
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 117
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 117
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 117
SDF-1/CXCR4 system in microvascular endothelial cells and skin from patients affected by systemic sclerosi 116
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 116
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 116
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 115
Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population. 115
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 114
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 114
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 113
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature. 112
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 112
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 112
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 111
Interstitial lung disease in systemic sclerosis: current and future treatment. 110
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 109
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. 108
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 108
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 108
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 107
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 106
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 106
Variations of neuronal nitric oxide synthase in systemic sclerosis skin 105
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 105
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 104
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. 104
FAS -670 gene promoter polymorphism confers susceptibility to systemic sclerosis 103
The Vessels Contribute to Fibrosis in Systemic Sclerosis 103
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial 103
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 102
Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells 101
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 99
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 99
Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor 99
Cellular players in angiogenesis during the course of systemic sclerosis. 98
FRI0414 Evaluation of a novel multi-analyte assay for the detection of autoantibodies in the diagnosis of systemic sclerosis 98
Surface expression of fractalkine receptor (CX3CR1) on CD4+/CD28-. T cells in RA patients and correlation with atherosclerotic damage 98
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). 98
IMPAIREMENT OF ENDOTHELIAL DIFFERENTIATION FROM MESENCHYMAL STEM CELLS (MSC) IN SYSTEMIC SCLEROSIS (SSC): A NEW TOOL IN PATHOGENETIC MECHANISM 97
SDF-1/CXCR4 system in microvascular endothelial cells and skin from patients affected by systemic sclerosis 95
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 95
Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis 94
Methotrexate: an old new drug in autoimmune disease. 93
Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) 93
Virtual skin biopsy by optical coherence tomography: the first quantitative imaging biomarker for scleroderma. 93
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy. 93
SDF-1 expression in the skin of SSc patients. 92
Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation? 92
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 92
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 92
Differential expression of SDF-1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis: pathogenetic implication. 91
Tocilizumab for the treatment of adult-onset Still's disease: Results from a case series 91
Pathogenesis of the endothelial damage and related factors. 90
Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC). 89
THE OCCURRENCE OF SUBCLINICAL AND CLINICAL ATHEROSCLEROSIS IN RHEUMATOID ARTHRITIS, RESULTS FROM THE 3-YEAR, MULTICENTER, PROSPECTIVE, OBSERVATIONAL, GIRRCS STUDY 89
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren’s syndrome 88
THE IL-33/ST2 PATHWAY IN SYSTEMIC SCLEROSIS 86
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 85
Mesenchymal stem cells transplantation in Systemic Sclerosis: comment on the article by ATJ Maria et al 84
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 83
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 83
Angiogenic cytokines and growth factors in systemic sclerosis. 82
Modificazioni della nitrossido-sintasi neuronale (nNOS) nella cute dei pazienti con sclerosi sistemica (SSc). 80
ASSOCIATION OF FAS-G670A GENE POLYMORPHISM WITH SYSTEMIC SCLEROSIS 80
VASCULAR SMOOTH MUSCLE CELLS (SMC) PROGENITORS: NEW PLAYERS IN SYSTEMIC SCLEROSIS (SSC) DEFECTIVE VESSEL REGENERATION. 79
Endothelial Progenitor Cells (EPC) characterization in systemic sclerosis (SSc) patients 76
 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis 74
Potential of stem cells in the treatment of rheumatic disease 73
Totale 11.063
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.620
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.620
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021276 0 0 0 0 0 0 0 0 0 45 171 60
2021/2022637 42 36 162 53 13 10 9 27 44 35 47 159
2022/20232.035 153 127 32 238 160 215 4 118 882 15 63 28
2023/2024484 71 35 28 51 50 158 10 25 1 22 9 24
2024/20251.974 39 38 187 62 339 154 224 149 432 82 142 126
2025/20263.270 235 346 144 428 405 275 648 136 310 343 0 0
Totale 11.430